EMA Authorised: Aerinaze (desloratadine;pseudophedrine sulfate) — Organon N.V.

View source ↗

Summary

EMA authorized Aerinaze, a fixed-dose combination of desloratadine and pseudoephedrine sulfate, for allergic rhinitis with seasonal symptoms. The marketing auth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Aerinaze (desloratadine and pseudoephedrine sulfate)

Snippet

Status: Authorised. Therapeutic area: Rhinitis, Allergic, Seasonal. MAH: Organon N.V.. Decision date: 07/04/2026